These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16571772)

  • 41. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
    Robbins SH; Bessou G; Cornillon A; Zucchini N; Rupp B; Ruzsics Z; Sacher T; Tomasello E; Vivier E; Koszinowski UH; Dalod M
    PLoS Pathog; 2007 Aug; 3(8):e123. PubMed ID: 17722980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of CD11c(+) hepatic dendritic cells in the induction of innate immune responses.
    Shu SA; Lian ZX; Chuang YH; Yang GX; Moritoki Y; Comstock SS; Zhong RQ; Ansari AA; Liu YJ; Gershwin ME
    Clin Exp Immunol; 2007 Aug; 149(2):335-43. PubMed ID: 17521321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Murine mammary adenocarcinoma cells transfected with p53 and/or Flt3L induce antitumor immune responses.
    Sang H; Pisarev VM; Chavez J; Robinson S; Guo Y; Hatcher L; Munger C; Talmadge CB; Solheim JC; Singh RK; Talmadge JE
    Cancer Gene Ther; 2005 Apr; 12(4):427-37. PubMed ID: 15678151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective dendritic cell responses against listeriosis induced by the short form of the deubiquitinating enzyme CYLD are inhibited by full-length CYLD.
    Wurm R; Just S; Wang X; Wex K; Schmid U; Blanchard N; Waisman A; Schild HJ; Deckert M; Naumann M; Schlüter D; Nishanth G
    Eur J Immunol; 2015 May; 45(5):1366-76. PubMed ID: 25675948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.
    Fernandez NC; Lozier A; Flament C; Ricciardi-Castagnoli P; Bellet D; Suter M; Perricaudet M; Tursz T; Maraskovsky E; Zitvogel L
    Nat Med; 1999 Apr; 5(4):405-11. PubMed ID: 10202929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice.
    Castellaneta A; Di Leo A; Francavilla R; Margiotta M; Barone M; Amoruso A; Troiani L; Thomson AW; Francavilla A
    Hepatology; 2006 Apr; 43(4):807-16. PubMed ID: 16557552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leukemia-associated activating mutation of Flt3 expands dendritic cells and alters T cell responses.
    Lau CM; Nish SA; Yogev N; Waisman A; Reiner SL; Reizis B
    J Exp Med; 2016 Mar; 213(3):415-31. PubMed ID: 26903243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer.
    Morse MA; Nair S; Fernandez-Casal M; Deng Y; St Peter M; Williams R; Hobeika A; Mosca P; Clay T; Cumming RI; Fisher E; Clavien P; Proia AD; Niedzwiecki D; Caron D; Lyerly HK
    J Clin Oncol; 2000 Dec; 18(23):3883-93. PubMed ID: 11099317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine.
    Cayeux S; Bukarica B; Buschow C; Charo J; Bunse M; Dörken B; Blankenstein T
    Gene Ther; 2007 Oct; 14(20):1481-91. PubMed ID: 17700709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells.
    Williams NS; Klem J; Puzanov IJ; Sivakumar PV; Bennett M; Kumar V
    J Immunol; 1999 Sep; 163(5):2648-56. PubMed ID: 10453005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine.
    Yo YT; Hsu KF; Shieh GS; Lo CW; Chang CC; Wu CL; Shiau AL
    Cancer Gene Ther; 2007 Nov; 14(11):904-17. PubMed ID: 17704754
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kruppel-like factor 4 (KLF4) promotes the survival of natural killer cells and maintains the number of conventional dendritic cells in the spleen.
    Park CS; Lee PH; Yamada T; Burns A; Shen Y; Puppi M; Lacorazza HD
    J Leukoc Biol; 2012 May; 91(5):739-50. PubMed ID: 22345706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leptin deficiency in vivo enhances the ability of splenic dendritic cells to activate T cells.
    Ramirez O; Garza KM
    Int Immunol; 2014 Nov; 26(11):627-36. PubMed ID: 24966213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model.
    Hung YP; Tu CC; Lai JI; Yang MH; Lee JM; Chao Y
    BMC Cancer; 2024 Jan; 24(1):136. PubMed ID: 38279092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acutely malnourished weanling mice administered Flt3 ligand can support a cell-mediated inflammatory response.
    Hillyer LM; Woodward B
    Cytokine; 2019 Jan; 113():39-49. PubMed ID: 30539781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis.
    Guimond M; Freud AG; Mao HC; Yu J; Blaser BW; Leong JW; Vandeusen JB; Dorrance A; Zhang J; Mackall CL; Caligiuri MA
    J Immunol; 2010 Mar; 184(6):2769-75. PubMed ID: 20142363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NK cells mediate Flt3 ligand-induced protection of dendritic cell precursors in vivo from the inhibition by prostate carcinoma in the murine bone marrow metastasis model.
    Tourkova IL; Yamabe K; Chatta G; Shurin GV; Shurin MR
    J Immunother; 2003; 26(6):468-72. PubMed ID: 14595214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutting edge: Flt3 ligand mediates STAT3-independent expansion but STAT3-dependent activation of myeloid-derived suppressor cells.
    Rosborough BR; Mathews LR; Matta BM; Liu Q; Raïch-Regué D; Thomson AW; Turnquist HR
    J Immunol; 2014 Apr; 192(8):3470-3. PubMed ID: 24639346
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice.
    Momenilandi M; Lévy R; Sobrino S; Li J; Lagresle-Peyrou C; Esmaeilzadeh H; Fayand A; Le Floc'h C; Guérin A; Della Mina E; Shearer D; Delmonte OM; Yatim A; Mulder K; Mancini M; Rinchai D; Denis A; Neehus AL; Balogh K; Brendle S; Rokni-Zadeh H; Changi-Ashtiani M; Seeleuthner Y; Deswarte C; Bessot B; Cremades C; Materna M; Cederholm A; Ogishi M; Philippot Q; Beganovic O; Ackermann M; Wuyts M; Khan T; Fouéré S; Herms F; Chanal J; Palterer B; Bruneau J; Molina TJ; Leclerc-Mercier S; Prétet JL; Youssefian L; Vahidnezhad H; Parvaneh N; Claeys KG; Schrijvers R; Luka M; Pérot P; Fourgeaud J; Nourrisson C; Poirier P; Jouanguy E; Boisson-Dupuis S; Bustamante J; Notarangelo LD; Christensen N; Landegren N; Abel L; Marr N; Six E; Langlais D; Waterboer T; Ginhoux F; Ma CS; Tangye SG; Meyts I; Lachmann N; Hu J; Shahrooei M; Bossuyt X; Casanova JL; Béziat V
    Cell; 2024 May; 187(11):2817-2837.e31. PubMed ID: 38701783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.